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Abstract: To gain a deeper understanding of the physicochemical phenomenon of self-assembled 
nanoparticles of different generations and ratios of poly (amidoamine) dendrimer (PAMAM) 
dendrimer and a short-stranded DNA (antisense oligonucleotide), multiple methods were used to 
characterize these nanoparticles including photon correlation spectroscopy (PCS); zeta potential 
measurement; and atomic force microscopy (AFM). PCS and AFM results revealed that, in 
contrast to larger molecules of DNA, smaller molecules produce more heterodisperse and large 
nanoparticles when they are condensed with a cationic dendrimer. AFM images also showed that 
such nanoparticles were spherical. The stability of the antisense content of the nanoparticles was 
investigated over different charge ratios using polyacrylamide gel electrophoresis. It was clear 
from such analyses that much more than charge neutrality point was required to obtain stable 
nanoparticles. For cell uptake, self-assembled nanoparticles were prepared with PAMAM G5 
and 5’-FITC labeled antisense and the uptake experiment was carried out in T47D cell culture. 
This investigation also shows that the cytotoxicity of the nanoparticles was dependent upon the 
generation and charge ratio of the PAMAM dendrimer, and the antisense concentration had no 
significant effect on the cytotoxicity.
Keywords: poly(amido amine) dendrimer, PAMAM, cytotoxicity, cell uptake, antisense 
oligonucleotide, epidermal growth factor receptor
Introduction
Gene therapy is a promising approach for the treatment of both acquired (eg, AIDS 
and cancers) and inherited (cystic fibrosis, hemophilia) diseases which are lacking 
effective drug treatments.1–4 During the last ten years many targets of gene therapy have 
been identified although there is still no satisfactory working vector to deliver genetic 
materials safely and efficiently in vivo.5 Gene delivery vectors can be roughly divided 
into two categories: viral and non-viral. Viral vectors are efficient in delivering a gene 
to the target cells although there are problems related to the safety and large-scale pro-
duction. Moreover, there are problems with viral vectors where the synthetic oligo- or 
polynucleotides (such as siRNAs or antisense oligodeoxynucleotides [ODNs]) cannot 
be easily inserted into the viruses and delivered satisfactorily. Non-viral (ie chemical) 
vectors are attractive because of their lower immunogenicity, greater safety and ease 
of preparation (for reviews, see6,7).In addition, chemical vectors can be formulated 
via a simple routine pharmaceutical process, and are increasingly used in experiments 
in vitro, in vivo and in clinical trials.8
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Among chemical vectors, dendrimers are uniquely 
efficient in the delivery of genetic materials into cells, espe-
cially in vitro.9,10 The size, shape and surface functionality 
of the dendrimer can be precisely controlled by designing 
an appropriate synthesis and modification process. The 
final products of a well-designed synthesis process have 
monodisperse structures. This is important especially when 
the hetero- or monodispersity of the used materials could 
greatly impact any responses in their medical or non-medical 
applications. Monodisperse raw materials often show very 
predictable consequences in their applications.
Since its introduction by Tomalia and colleagues in 
1984,11 the poly(amido amine) dendrimer (PAMAM) has 
become widely used in many fields.12–15 One of these being 
as a gene delivery vehicle and as such it has become one 
of the most successful vectors in the field of in vitro gene 
delivery.16–19 PAMAM dendrimers are a group of symmetri-
cal hyper-branched macromolecules which, at generations 
higher than five, have a three-dimensional spheroid or 
elliptical shape with a diameter of approximately 6–12 nM, 
depending on the core structure, surface groups and gen-
eration (for more details of nomenclatures about PAMAM 
dendrimers, see).12 Full generations of PAMAM have pri-
mary amino groups at their surface which are protonated 
at a physiological pH; therefore they can interact with the 
phosphate groups of nucleic acid strings, and condense 
them into more stable and protected particles from tens 
to many hundreds of nanometers in size (self-assembled 
nanoparticles of PAMAM/ANS). However, one problem 
with using PAMAMs especially in vitro is that it is toxic at 
the higher generations which are used for the efficient deliv-
ery of nucleic acids.20,21 For example, Polyfect® (which is a 
generation 6 PAMAM) and Superfect® (fractured generation 
6 PAMAM) have been proved to have noticeable cyto- and 
genotoxicities in vitro.22 At the same time, lower generations 
of PAMAM such as generation 5, while having the ability 
to condense both DNA or RNA, have a lower toxicity.23,24 
However, very little is known about these lower generations. 
In order to elucidate more about their interaction with nucleic 
acids we selected, (based on previous work by a member of 
our group), an antisense oligonucleotide (ANS) designed 
against epidermal growth factor receptor (EGFR).24 Some 
of its characteristics were then evaluated prior to biological 
application. The relationship between EGFR and the poor 
prognosis of some types of cancers, especially breast, ovar-
ian, head and neck cancer, has been established and the 
overexpression of this receptor is known to be correlated 
to the division, growth and migration of tumor cells.25 
On the other hand, recent clinical trials for example using 
Mipomersen® and previously commercialized Vitravene®, an 
antisense drug, show that antisense therapy still has value in 
the field of genetic research and the therapeutic downregula-
tion of a gene function.26,27 Antisense oligodeoxynucleotides 
(ANS-ODNs) are sequences of short single-stranded ODNs, 
often 19–25 bases in length. They can hybridize to a specific 
mRNA in the cytoplasm or nucleus via the Watson-Crick 
base pairing mechanism, which leads to the blocking of 
mRNA translation, then sensitization of target mRNA to 
specific RNase-H, which finally leads to degradation of the 
mRNA.28 ANS-ODNs are hydrophilic macromolecules that 
need to be properly delivered like any other genetic material 
to the defined cells and to the cytoplasm. The physicochemi-
cal properties of these smaller macromolecules seem to be 
different from those of their heavier family members; for 
example DNAzyme, ribozyme or other kinds of gene thera-
peutics (eg, plasmids), when they interact with chemical 
vectors. Moreover, the physicochemical characterization 
of non-viral vectors is an important step before any in vivo 
or in vitro application.
Thus the main objectives of this study were to investigate 
the physicochemical properties (size, morphology and zeta 
potential) which are important for the biological activity of 
self-assembled PAMAM/ANS-ODN nanoparticles, at dif-
ferent generations of PAMAM, to evaluate the cytotoxicity 
of the prepared nanoparticles at different charge ratios, and 
to determine the impact of this vector on the cell uptake of 
self-assembled nanoparticles in T47D cell culture. The 
difference between the interaction of big double-stranded 
DNA molecules and small single-stranded DNA (EGFR 
ANS) with PAMAM dendrimer is also discussed.
Method
Materials
Polyamidoamine dendrimer generations two, three, four 
and five (PAMAM G2, G3, G4, G5), which have ethylene-
diamine as an initiator core, 16, 32, 64 and 128 primary 
amino groups at their surface and a molecular weight 
of 3256, 6909, 14215 and 28826 Da respectively, were 
synthesized according to the previously reported method.29 
Briefly, this synthesis was done via iterative reactions of 
Michael addition of methylacrylate to the ethylenediamine 
for half generations, followed by exhaustive amidation of 
half generations by high excess methanolic ethylenediamine 
at the next step for full generations. The product at each step 
of the synthesis was purified by three methods: azeotropic 
distillation, high vacuum overnight, and ultrafiltration with International Journal of Nanomedicine 2010:5 361
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defined molecular weight cut-offs, followed by the freeze 
drying of the results. They were later characterized by,1 
proton nuclear magnetic resonance (H-NMR) and Fourier-
transform infrared spectrometry (FTIR). The sequence of 
phosphorothioated EGFR ANS 5′(TTT CTT TTC CTC 
CAG AGC CCG)3′ was according to that reported by Petch 
and colleagues.28 5′-FITC labeled phosphorothioated EGFR 
ANS FITC-5′(TTT CTT TTC CTC CAG AGC CCG)3’ was 
used for cell uptake investigations. All sequences were 
purchased from TIB Molbiol GmbH, Berlin, Germany or 
Bioneer Daejeon, Korea and used as received. All solvents 
and reagents were analytical or high pressure liquid chroma-
tography (HPLC) grade and purchased from Merck KGaA, 
Darmstadt, Germany.
Preparation of self-assembled 
nanoparticles for particle size  
and zeta potential analysis
Self-assembled nanoparticles of PAMAM with ANS were 
prepared in 5% (w/v) dextrose, pH 7, at different molar ratios 
of PAMAM primary amino groups to ANS phosphate groups 
(N/P ratio). Separate stock solutions of 5 mg/mL of PAMAM 
for different generations in 5% dextrose were prepared. Stock 
solution of 100 µM of EGFR ANS in diethylpyrocarbonate 
(DEPC) treated water was constructed. For preparation of 
N/P ratio of ten, 5 µL of PAMAM solution containing 1 µM 
primary amine was diluted to 50 µL by 5% dextrose and 
added drop-wise to 10 µM of ANS solution diluted with 5% 
dextrose. For N/P ratios of 2.5, 5 and 20 the volume of ANS 
was fixed at the same volume of N/P 10, while the proper 
relative volume was taken from PAMAM solution. In the 
case of N/P ratio of 0.5, the stock solution was diluted by 
a factor of 10 to make it possible to take the exact volume. 
Then the nanoparticles were mixed by pipetting up and down 
15 times and then incubated for 10–15 minutes at room tem-
perature. Self-assembled nanoparticles of polyethyleneimine 
(PEI)/ANS were prepared according to the method described 
by Boussif and colleagues.30
For particle size analysis, 100 µl of nanoparticles was 
diluted 1:10 in 5% dextrose before the particle size and/or 
zeta potential of nanoparticles was evaluated using Malvern 
Nanosizer, ZN series, Malvern Instruments Ltd, Malvern, 
UK after substantially vortexing of the mixture before 
measurement.
Atomic force microscopy (AFM) analysis
For AFM analysis, different N/P ratios of PAMAM G5 
were selected and diluted 1:100 with double-distilled H2O. 
After 10 minutes incubation at room temperature, 5 µL of 
each formulation was then added on a freshly cleaved mica 
sheet. After 5 minutes incubation at room temperature, the 
sheet was washed twice with 100 µL of double-distilled 
H2O. The prepared samples were first dried from the edge 
of the mica sheet by using a paper tissue, then by exposure 
to a gentle air flow for 10 minutes. Thereafter, the samples 
were subjected immediately to AFM study using a DME 
DualScope/Rasterscope™ SPM (Danish micro engineering 
Herlev, Denmark). The AFM studies were performed at AC 
mode, spring constant of 2.8 N/m with resonance frequency 
of 100 KHz, speed of 30–40 µm/s, and force constant of 42 N. 
Processing of topographic or phase images were carried out 
using DME SPM software version 2.1.1.2.
Polyacrylamide gel electrophoresis 
(PAge) analysis
PAMAM G5/ANS nanoparticles at various N/P ratios were 
prepared as described earlier, and then diluted in double-dis-
tilled H2O. Nanoparticles (16 µL) containing 1.6 µg of ANS 
were mixed with 4 µL of urea loading dye (480 mg urea, 
40 µL of 0.5 M ethylenediaminetetraacetic acid (EDTA), 
2 µL of 1 M Tris pH 7.5 and 140 mg bromphenol blue per 
1 mL of dye solution). After mixing, the suspension was 
loaded in each well of 16% polyacrylamide gel which was 
electrophoresed for 90 minutes at 250 volts. The gel was then 
soaked in 0.5% ethidium bromide solution for 20 minutes 
then visualized under UV illumination using Bio Doc it 
(UVPCO, UK).
cell culture
T47D cells (National Cell Bank of Iran, Pasteur Institute, 
Human breast cancer passage number between 15 and 
40) were cultured in RPMI 1640 (Gibco,® Invitrogen Ltd, 
Paisley UK) supplemented with 10% fetal bovine serum 
(FBS) (Gibco), streptomycin (100 ng/mL), and penicillin 
(100 units/mL) in 37°C, 5% humidified CO2 incubator. The 
cells were passaged 2–3 times per week.
cell uptake experiments
Cellular uptake of EGFR AS/PAMAM G5 nanoparticles 
was investigated using 5’end FITC-labeled EGFR ANS. Two 
days before the experiment, the cells were seeded in 6-well 
plates 4 × 105 cells/well in 3 mL of the medium. Then on the 
day of transfection, the medium was removed, the cells were 
washed with phosphate buffered saline (PBS), and 400 µL 
of nanoparticles diluted 1:5 in FBS-free RPMI, at different 
N/P ratios for PAMAM G5 were added to the cells. The final International Journal of Nanomedicine 2010:5 362
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concentration of the ANS was 1 µM. The cells were incubated 
for 4 hours at 37°C. After incubation, the medium of each 
well was removed and washed with PBS and analyzed by 
inverted fluorescent microscope (Olympus IX50, Olympus 
Inc.) using 100X and 400X magnifications.
cytotoxicity assays
The cytotoxicity of different generations of PAMAM nanopar-
ticles was studied using MTT assay (3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyltetrazolium bromide [Sigma Aldrich Munich, 
Germany]). PAMAM G5 at different N/P ratios and two 
different ANS concentrations (0.5 and 1 µM), and PAMAM 
G2-G4 at fixed N/P ratio of 10 were prepared according to the 
described method. After mixing and incubation of the proper 
dilution of PAMAM and ANS solution, the nanoparticles 
were diluted 1:10 in FBS-free RPMI medium. T47D cells 
(1 × 104 cells/well) were seeded in 96-well plates 48 hours 
before transfection. On the day of transfection, the medium 
was removed from the wells and 180 µL of freshly prepared 
nanoparticles were incubated with the cells. Proper control 
of FBS-free RPMI 1640, ANS alone, and PAMAM G2, G3, 
G4 and G5 alone at exact concentrations that were used for 
preparing different N/P ratios were used but without the addi-
tion of ANS. The incubation time was 4 hours, after which the 
medium was replaced with growth medium after washing of 
the cells by PBS. After 48 hours incubation, 25 µL of MTT 
dye (4 mg/mL) was added to each well and the cells were 
incubated for a further 3 hours at 37°C. Then the medium 
was removed and 100 µl dimethyl sulphoxide (DMSO) was 
added to each well. The plates were shaken for 30 seconds 
and the absorbance of Formazan dye was recorded at 540 nM 
using a microplate reader (Sunrise,™ Tecan, Grödig, Austria). 
The viability of the cells was calculated by employing of the 
following equation:
Viability
OD OD
OD OD
treatment blank
control blank
(%) =
−
−
× 100
where Viability is the cell viability as a percentage of control, 
ODtreatment, ODcontrol, and ODblank are the measured optical 
density of the treated, RPMI and blank wells at a wavelength 
of 540 nm, respectively.
statistical analysis
For comparison of two means, Student t-test was applied, 
and for more than two means, one way analysis of variance 
(ANOVA) was selected with Bonferroni post hoc. P value 
 0.05 was considered as significantly different in all cases, 
unless otherwise mentioned.
Results
size and zeta potential analysis  
of the nanoparticles
Self-assembled nanoparticles of the G2 through G4 of 
PAMAM with ANS at N/P ratio of 10 had a peak between the 
ranges of 40–500 nm. For G5 at different N/P ratios a peak in 
the range of 40–1100 nm was repeatable (Figures 1a, 1b and 
Table 1). The higher the N/P ratio, the narrower the observed 
particle distribution (Table 1). For example, for generation 
5 the particles larger than 800 nm, present at the N/P ratio 
of 0.5 were not observed at higher N/P ratios (Figure1b and 
Table 1). In some cases, especially for the lower generations, 
the graph was multimodal instead of a single peak. Various 
repeats of the measurements revealed that by increasing the 
charge ratios, the probability of observing multiple peaks 
decreased.
The zeta potential of nanoparticles showed an ascending 
pattern from lower to higher N/P ratios which finally reached 
a plateau at higher charge ratios (Figure 1c). For G5 at N/P 
ratio of 0.5, the zeta potential was near to positive (5.2 ± 
4.8 mV) and at N/P ratios of 10 and 20 the average surface 
charge of particles was 15.7 ± 5.1 mV and 18.4 ± 3.4 mV , 
respectively (Figure 1c, n = 3).
Despite the results observed for PAMAM, nanoparticles 
of PEI/ANS showed a strongly positive charge of 42.3 ± 5.9 
(mean ± standard deviation [SD]) at N/P of 6.
AFM experiment
Figures 2a, b, c and d are representative of the AFM phase 
or topographic images of nanoparticles and surface profile 
of PAMAM G5/ANS at charge ratios of 0.5, 5, 10 and 20, 
respectively. Particles at different charge ratios were mea-
sured in AFM pictures using the DME software, summarized 
in Table 1. Similar to the PCS results, the nanoparticles at 
a charge ratio of 0.5 were bigger than at higher N/P ratios 
(Figure 2a and Table 1). Table 1 shows that the smallest 
size distribution belongs to the N/P ratio of 20, in which 
nearly all the particles had a size distribution of less than 
300 nm. Particles at different ratios had both spherical and 
rod-like shapes but AFM evaluation suggested that at higher 
charge ratios the spherical shape became the predominant 
morphology.
PAge analysis
PAGE experiments showed that N/P ratios higher than 2.5 
were necessary in order to stabilize and retard the ANS 
content of PAMAM G5/ANS self-assembled nanoparticles. 
Figure 3 shows that the lower N/P ratio of 0.5 could also move International Journal of Nanomedicine 2010:5 363
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through the gel at almost the same speed as the naked ANS. 
But at N/P ratios of 2.5 or higher, almost all of the ANS cargo 
remained in the wells.
cellular uptake of nanoparticles by 
human breast cancer T47D cells
Figure 4 shows the cellular uptake of self-assembled 
nanoparticles of PAMAM G5 with FITC-tagged-ANS at 
different N/P ratios. After 4 hours incubation, the majority 
of naked FITC-ANS were attached to the cell surface 
which can be seen as pale green spots in Figure 4a and 
only a negligible amount of them entered the cytoplasm. 
At an N/P ratio of 0.5, PAMAM/ANS nanoparticles were 
not effectively taken up and many were bound to the 
cell surface (Figure 4b). But for N/P ratios of 10 and 20, 
the cytoplasm and nucleus of the T47D cells were the 
main location of the FITC-ANS/PAMAM G5 complexes 
(Figures. 4c–d).
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Figure1 size distribution by intensity of PAMAM/ANs nanoparticles (a and b) and Zeta potential graphs of different N/P ratios of PAMAM g3 ( ), g4 ( ), and g5 ( ) in 5% 
dextrose (c). Fixed concentrations of 500 nM of ANs in 5% dextrose were mixed with different generations of PAMAM at N/P ratio of 10 a). Part a) shows all size distributions 
at the same intensity scale in one graph.   A peak of larger aggregates of g2/ANs nanoparticles can be observed in part a). Nanoparticles of various N/P ratios of PAMAM g5 
which were formulated in 5% dextrose are shown in part b). In part c), the represented data are means of two (without error bar) or three (mean ± sD) measurements.
Abbreviations: PAMAM, poly(amidoamine) dendrimer; sD, standard deviation; ANs, antisense oligonucleotide.
Table 1 size distribution of nanoparticles determined by AFM and Pcs methods. For AFM, n particles in different images were measured 
by the software of the device and then expressed as mean ± sD
Particle size estimation (nm)
N/P ratio 0.5 5 10 20
AFM (Mean ± sD) 652.32 ± 289.7  
(n = 57)*
423.35 ± 173.13  
(n = 71)
244.81 ± 149.70  
(n = 67)
203.51 ± 108.14   
(n = 85)
Pcs (Mean z-Average ± sD)  
(n = 3)
534 ± 373 355 ± 163 315 ± 130 144 ± 85
Notes: *n is the number of measured particles in AFM pictures.
Abbreviations: AFM, atomic force microscopy; Pcs, photon correlation spectroscopy; sD, standard deviation.International Journal of Nanomedicine 2010:5 364
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Toxicity of nanoparticles
The toxicity of the nanoparticles was dependent on PAMAM 
generations and N/P ratio. The cell viability of PAMAM G2 
and G3 nanoparticles was over 80%, whereas after exposure 
to G4 and G5 self-assembled nanoparticles the cell viability 
was approximately 60%, depending on the applied N/P ratio. 
The toxicity of G2 with or without ANS was not more than 
that of ANS alone (Figure 5a). At equal amine concentrations, 
significantly higher toxicity was observed as the generation 
increased (Figure 5a). Concentrations of 500 and 1000 nM of 
naked ANS had no significant toxicity on T47D cells, whereas 
the naked carrier caused toxicity proportional to the con-
centration. There was no significant difference between the 
toxicity of these two concentrations of ANS, whether it was 
naked or condensed by PAMAM G5. The result was the same 
for different N/P ratios in the case of PAMAM G5, except for 
N/P of 20 (One-way ANOVA, Bonferroni post-hoc, P value 
 0.05). At this ratio, higher ANS concentrations had greater 
toxicity than the lower concentrations (Figure 5b). Moreover, 
for each charge ratio of G5, there was no difference between 
Figure 2 AFM phase or topographic images and their corresponding surface profile of the selected section. The charge ratios were as 0.5 A), 5 B), 10 C), and 20 D).
Abbreviation: AFM, atomic force microscopy.International Journal of Nanomedicine 2010:5 365
Physicochemical and biological properties of PAMAM/antisense nanoparticles Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
Ladder N/P = 20 N/P = 10 N/P = 5 N/P = 2.5 N/P = 0.5 AS
Figure 3 PAge analysis of PAMAM g5/ANs nanoparticles carried out at various N/P ratios shown in the image.
Abbreviations: PAMAM, poly(amidoamine) dendrimer; ANs, antisense oligonucleotide; PAge, polyacrylamide gel electrophoresis.
a) b)
c) d)
Figure 4 T47D cells uptake of PAMAM g5/FITc-ANs nanoparticles at charge ratios of 0.5 b), 10 c), 20 d), in comparison with the FITc-ANs alone a). The magnification of 
each image was 400X.
Abbreviations: PAMAM, poly(amidoamine) dendrimer; ANs, antisense oligonucleotide.International Journal of Nanomedicine 2010:5 366
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the toxicity of self-assembled nanoparticles and polymer 
alone at the same concentration, again except in the case of 
the charge ratio of 20 (t-test, P value  0.05, for N/P of 20 
P value  0.001). It should be noted that all nanoparticles 
formed at more than charge neutrality had greater toxic 
effects at both concentrations of ANS than the naked ANS 
(Figure 5a–b). PEI/ANS nanoparticles were significantly 
more toxic at N/P ratio 6 (which has been reported as the 
efficient N/P ratio in transfection) than PAMAM G5 even at 
higher N/P ratios.
Discussion
In non-viral gene delivery, the binding and protection of 
nucleic acids is a critical step in the delivery of gene thera-
peutics to specific targets.31,32 Except for some special routes 
of delivery, of these unstable hydrophilic macromolecules, 
(eg, conjugation of macromolecules to the cell penetrating 
peptides26 or old methods of sonoporation, electroporation, 
and applying hydrodynamic pressure), condensation with a 
polycation is an important and commonly used route for their 
delivery to the cytoplasm or nucleus of the target cells.33,34
The polycationic dendrimer of PAMAM in all genera-
tions can interact with DNA molecules and form nanopar-
ticles which have some partially N/P ratio dependent 
features.35–37
The PCS results showed that from the lower N/P ratios 
to the higher N/P ratios, the deviation from the mean size 
of the nanoparticles decreased, and the same tendency can 
be observed for the AFM results (Table 1). An insufficient 
amount of counter ionization of the dendrimer, at lower N/P 
ratios can lead to inefficient compaction of the oligonucle-
otides. This effect, accompanied by a lower surface charge 
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Figure 5 MTT assay graphs of PAMAM/ANS nanoparticles. In Figure 5a, multiple generations of PAMAM at fixed a N/P ratio of 10 (black filled columns) are compared with 
their corresponding PAMAM concentration without ANs (hatched columns), polyethyleneimine (PeI) at N/P ratio of 6, and negative control of FBs-free rPMI.
Abbreviations: PAMAM, poly(amidoamine) dendrimer. ANs, antisense oligonucleotide; N/P, PAMAM, primary amino groups to ANs phosphate groups; FBs, fetal bovine 
albumin; PeI, polyethyleneimine.
Figure 5b shows PAMAM G5 at different charge ratios of 0.5, 2.5, 5, 10, and 20. Their cytotoxicity was evaluated at two different concentrations of 500 nM (black filled 
columns) and 1000 nM (dotted columns) and also in comparison with their corresponding dendrimer concentrations without ANs (hatched columns). The PeI (N/P of 6) and 
naked ANs (500 nM) were positive and FBs-free rPMI was negative controls.   All represented data are means of eight different measurements relative to the negative control 
(rPMI) ± standard error of mean. *was significantly different when each treatment was compared with the ANS alone concentration treatment (t-test, P value  0.05). **No 
statistical difference (One-way ANOVA or student t-test, P value  0.05).
Abbreviations: PAMAM, poly(amidoamine) dendrimer; ANs, antisense oligonucleotide; N/P, PAMAM, primary amino groups to ANs phosphate groups; FBs, fetal bovine 
albumin; PeI, polyethyleneimine; ANOVA, analysis of variance.International Journal of Nanomedicine 2010:5 367
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density of the resulting nanoparticles of the dendrimer and 
ANS, can cause the nanoparticles to easily produce large 
aggregates in the solution. These can be detected by PCS 
graphs (Figure 1b graph of N/P = 0.5) and AFM pictures 
(Figure 2a). Several research groups have reported such 
behavior for heavy and large DNA molecules. Fant and 
colleagues35 studied the condensation of plasmid luciferase 
(4331 bp) by PAMAM G5 as a synthetic histone model. 
They also reported large aggregates for ANS at lower N/P 
ratios, using the PCS method. In our study, the PCS and AFM 
images showed that the aggregation of particles at lower 
charge ratio of dendrimer to small DNA occurred quite often, 
and sometimes such large aggregates were observed at N/P 
ratios of 10 and 20 (see Figure1 and 2, and large aggregates 
at higher N/P in Figure 1a, N/P = 10 of G2). It is obvious that 
the ionic strength and pH of the solution play a prominent role 
in the compaction of polynucleotides with polycations.31,32 
Higher concentrations of cations in the solution can greatly 
affect the compaction efficiency of polycationic polymer, and 
lower pH can induce more protonation of primary amines of 
polycations, such as PAMAM. In comparison with the other 
solutions, eg, 150 mM NaCl,35 or 10–20 mM HEPES,17 and 
distilled water,19 the dextrose/water solution that was used in 
this study had a moderate ionic strength and pH 6.5 at which 
nearly all the primary amines of the dendrimer are protonated. 
Therefore, it was expected that the resulting self-assembled 
nanoparticles would have a smaller size in comparison to 
those in the previously reported experiments of PAMAM 
with DNA.19 But the PCS graphs and AFM images were not 
consistent with this hypothesis.
In their study on salmon testes DNA condensation 
by PAMAM G2 and G3 using small angle x-ray scatter-
ing, Su and colleagues36 observed that the main structure 
for G2/DNA aggregations was hexagonal, while for the 
G3/DNA complexes a square lattice was observed. Large 
DNA molecules cannot bend around these lower generations 
of PAMAM because of the high energy required for this to 
occur. However, for higher generations (G4 and bigger), 
DNA molecules of 1-50 kbp always have a final compac-
tion morphology of toroids and perfectly hexagonal lattice 
structures, which constitute the majority (nearly 80%) of 
particle morphologies.
In another study, Carnerup and colleagues37 reported that 
the size of these nanoparticles was around 100 nm when they 
condense the luciferase plasmid DNA with PAMAM G1, G2 
and G4 at more than neutrality charge ratios. However, for 
higher generations (in their study G4), this size is a result of 
the DNA double helix minimum energy and total energy cost 
effectiveness, which causes the DNA helix to bend around the 
dendrimer molecules when it is compacted by them.32,37,38 In 
the case of small DNA molecules, eg, ANS, it seems that it 
is difficult to achieve a uniform hexagonal lattice formation 
and the morphology of toroids even for PAMAM G5 in view 
of the thermodynamic and kinetic theory of toroid forma-
tion.32 As a result, there was a considerable heterogeneity 
in the particle size estimated by PCS or visualized by AFM 
methods (Figures 1–2 and Table 1), which are not in accord 
with the previously reported monodisperse data in the case of 
PAMAM,39 (and our experiments on compaction of plasmid 
EGFP by PAMAM G5). However, detailed studies using x-ray 
scattering are needed to confirm the internal structure of the 
self-assembled nanoparticles of ANS/PAMAM.
Gel electrophoresis can show the efficiency of the 
compaction and protection of ANS by polycations. Yoo 
and colleagues40 evaluated the gel retardation of an 18-mer 
ANS ODN and PAMAM G5 at N/P ratios of 35 and 60. 
They reported that at these N/P ratios the ANS/PAMAM 
G5 nanoparticles are stable in the agarose gel. But our 
results show that there is no need for a very high N/P ratio 
for retardation of ANS by PAMAM G5. A 2.5- fold excess 
of dendrimer amine versus phosphate group was sufficient 
to stabilize these ionic complexes toward electrophoretic 
mobility.
Lower charge ratios of PAMAM G5/ANS cannot affect 
the cell surface, and the particles, although attached, were not 
able to effectively enter the cells. It is obvious from Figure 4b 
that an excess of cationic dendrimer is necessary to cause the 
uptake of nanoparticles. Surface charge and particle size are 
important factors determining how the nanoparticles interact 
with the biological environment and membranes.41 Interac-
tion of PAMAM G5 with ANS forms larger particles, and 
because of their size, their interaction with the cell surface, 
and consequently the cell uptake behavior, could be different 
from that of big DNA/PAMAM self-assembled nanopar-
ticles. Recently, many articles have proved the formation of 
holes at the lipid bilayer model membrane and cell surface 
membrane following exposure to even non-cytotoxic con-
centrations of cationic nanoparticles and specially PAMAM 
dendrimers.42–45 These transient pores, which form quickly 
(within micro- to milliseconds),42 exist long enough that even 
large nanoparticles (such as PAMAM/ANS nanoparticles) 
can easily enter the cells. Obviously, higher charge ratios 
have more impact on the cell membrane, because the prob-
ability of the interaction of the dendrimers with the membrane 
will increase. It is possible that the lower charge of cationic 
particles at the N/P ratio of 0.5 was not capable of inducing International Journal of Nanomedicine 2010:5 368
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transient nanopores in the lipid bilayer of cell membrane, 
which is one of the mechanisms responsible for cell uptake 
of cationic nanoparticles.46,47 Another explanation for this 
observation could be the effect of a higher charge ratio 
causing higher affinity to negatively charged cell surfaces. 
This affinity can induce more endocytosis of the particles. 
The mechanism of uptake needs to be clarified, but it is pos-
sible that the hole formation may be the main mechanism, 
since nanoparticles attach to the cell membrane at the lower 
charge ratio, but cannot enter the cells (Figure 4b). For large 
particles of PAMAM/ANS, other mechanisms of uptake, 
such as macropinocytosis, should be considered in further 
investigations as well.
The toxicity of cationic dendrimers, polymers and their 
nanoparticles are well-known.48 In this paper we have shown 
that the toxicity of self-assembled nanoparticles depends on 
both the PAMAM concentration and generation. At the same 
amine molarities, higher generations have higher cytotoxic-
ity compared with the lower generations (Figure 5 a–b). Yoo 
and colleagues40 reported the toxicity of naked PAMAM and 
PAMAM/ANS nanoparticles in the absence of serum. The 
observed cytotoxicity of naked PAMAM G5 and PAMAM 
G5/ANS (500 nM ANS concentration) was the same as in our 
experiment (around 60% cell viability), but at 1 µM concen-
tration it was different. Naked ANS concentration at selected 
amounts had no effect on the cell viability. The effect of ANS 
on the target gene is concentration dependent, but only in the 
case that it can easily enter the cells and reach its target. Lower 
N/P ratios cannot effectively cause cell uptake (Figure 4), 
so there is no difference between 500 nM and 1 µM ANS at 
this ratio. At higher N/P ratios (10 and 20), at which the ANS 
cargo can enter the cells effectively (Figure 4), the differ-
ence between the cytotoxicity of two ANS concentrations is 
obvious (Figure 5b). Further investigations of the other ANS 
concentrations are necessary to conclusively prove this effect. 
In addition, further studies on these nanoparticles to identify 
the final effect of ANS and dendrimers are needed.49
Conclusion
In this study we have shown that cationic PAMAM G5 
dendrimers form larger nanoparticles with ANS than 
with plasmid DNA and can deliver ANS oligonucleotides 
inside the cells, with moderate toxicity on the cell culture. 
The destiny of these gene nanoparticles when they enter to 
the cells should be investigated further. Moreover, there are 
no comprehensive studies of the effect of PAMAM/ANS 
nanoparticles on the genomic content of the cells, and this 
also requires further investigation.
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